Using information on KIRs and their HLA ligands, we further tested receptor-ligand models and summation models without revealing markedly significant differences between patients and controls, albeit we observed a trend pointing at a minor protective effect of a low number of inhibitory KIR/KIR-ligand pairs.
← all excerpts
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia.
1
—
—